Absci ABSI
NASDAQ ABSI
$8.82 +0.02 (+0.23%)
As of: Sep 4, 2026 · 3:59 PM EDT

Absci (ABSI) Cash from Investing Activities (2020 - 2026)

Absci (ABSI) posted Cash from Investing Activities of $7.4 million for Q1 2026, down 62.34% sequentially from $19.5 million in Q4 2025, and up 148.94% YoY from $3.0 million in Q1 2025.

Analysis

Absci (ABSI) Cash from Investing Activities (2020 - 2026) Analysis & Trends

Absci has reported Cash from Investing Activities for 7 years, with the latest figure at $7.4 million in Q1 2026.

  • Quarterly Cash from Investing Activities rose 148.94% year-over-year to $7.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$27.8 million (down 238.35% YoY) and the FY2025 annual result came in at -$50.2 million, down 20.64% from the prior year.
  • Cash from Investing Activities retreated to $7.4 million in Q1 2026 per ABSI's latest filing, from $19.5 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $70.2 million in Q2 2023 and troughed at -$78.7 million in Q3 2022.
  • A 5-year average of -$7.6 million and a median of $1.3 million in 2024 frame the typical range for Cash from Investing Activities.
  • The sharpest annual moves came in 2022 and 2023: Cash from Investing Activities slumped 1054.3% in 2022, then jumped 725.07% in 2023.
  • Over 5 years, Cash from Investing Activities stood at -$30.2 million in 2022, then surged by 162.82% to $19.0 million in 2023, then grew by 0.45% to $19.0 million in 2024, then increased by 2.65% to $19.5 million in 2025, then tumbled by 62.34% to $7.4 million in 2026.
  • According to Business Quant data, Cash from Investing Activities over the past three periods registered $7.4 million, $19.5 million, and -$63.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -45.80 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -92.70 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 329.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -1.66 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -49.35 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -363.46 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -229.72 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 24.51 Mn
10 Absci 1.39 Bn 1.19 Bn - 24.07 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 24.07 Mn
Mar 31, 2026 7.36 Mn
Dec 31, 2025 19.55 Mn
Sep 30, 2025 -63.70 Mn
Jun 30, 2025 9.04 Mn
Mar 31, 2025 -15.04 Mn
Dec 31, 2024 19.04 Mn
Sep 30, 2024 14.81 Mn
Jun 30, 2024 1.26 Mn
Mar 31, 2024 -76.68 Mn
Dec 31, 2023 18.96 Mn
Sep 30, 2023 20.14 Mn
Jun 30, 2023 70.15 Mn
Mar 31, 2023 -27.30 Mn
Dec 31, 2022 -30.18 Mn
Sep 30, 2022 -78.72 Mn
Jun 30, 2022 -11.22 Mn
Mar 31, 2022 -6.86 Mn
Dec 31, 2021 -8.32 Mn
Sep 30, 2021 -6.82 Mn